A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor

Condition:   Thymic Cancer Intervention:   Drug: Palbociclib Sponsor:   Samsung Medical Center Not yet recruiting - verified July 2017 (Source: ClinicalTrials.gov)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uK9hTO
via IFTTT